Biotechnology Report

The Wall Street Transcript has just published its Biotechnology issue, a report offering a timely review of the sector to serious investors and industry executives. This 80-page feature contains industry commentary through an in-depth industry roundtable, an Industry Analyst and CEOs from 17 sector firms. Topics covered: Stock price performance - M&A outlook - Financing environment - Role of Big Pharma - Tuck-in acquisitions - Asset sales from small cap biotechs - FDA actions - PDUFA dates - Higher costs of drug development - Hybrid companies - Pharmaeconomics - Off-patent drugs - Stock recommendations - Stocks to avoid